Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (221-230 of 315) with videos related to

Pageof 32
Sort By:
Transplantation|April 17, 2003
FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host diseaseMurad Y Yunusov, George E Georges, Rainer Storb, et al.
Arthritis and Rheumatism|May 30, 2006
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosisRichard A Nash, Peter A McSweeney, J Lee Nelson, et al.
American Journal of Hematology|October 23, 2019
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemiaElizabeth F Krakow, Boglarka Gyurkocza, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2015
Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic TransplantationJennifer E Vaughn, Barry E Storer, Philippe Armand, et al.
Haematologica|October 12, 2010
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of ageEmilie Castermans, Muriel Hannon, Jacques Dutrieux, et al.
Cancer Research|February 27, 2009
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211Hirohisa Nakamae, D Scott Wilbur, Donald K Hamlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiationYunchuan Ding, Marcello Rotta, Scott S Graves, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2010
Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of ageDario Sangiolo, Rainer Storb, H Joachim Deeg, et al.
Leukemia|January 25, 2020
Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AMLLinde M Morsink, Megan Othus, Evandro D Bezerra, et al.
Transplantation|March 30, 2006
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantationLauri Burroughs, Marco Mielcarek, Wendy Leisenring, et al.
Pageof 32

Showing results (221-230 of 315) with videos related to

Sort By:
Pageof 32
Transplantation|April 17, 2003
FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host diseaseMurad Y Yunusov, George E Georges, Rainer Storb, et al.
Arthritis and Rheumatism|May 30, 2006
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosisRichard A Nash, Peter A McSweeney, J Lee Nelson, et al.
American Journal of Hematology|October 23, 2019
Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemiaElizabeth F Krakow, Boglarka Gyurkocza, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2015
Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic TransplantationJennifer E Vaughn, Barry E Storer, Philippe Armand, et al.
Haematologica|October 12, 2010
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of ageEmilie Castermans, Muriel Hannon, Jacques Dutrieux, et al.
Cancer Research|February 27, 2009
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211Hirohisa Nakamae, D Scott Wilbur, Donald K Hamlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiationYunchuan Ding, Marcello Rotta, Scott S Graves, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2010
Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of ageDario Sangiolo, Rainer Storb, H Joachim Deeg, et al.
Leukemia|January 25, 2020
Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AMLLinde M Morsink, Megan Othus, Evandro D Bezerra, et al.
Transplantation|March 30, 2006
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantationLauri Burroughs, Marco Mielcarek, Wendy Leisenring, et al.
Pageof 32